article thumbnail

RVAC and University of Pennsylvania to develop mRNA vaccines

Pharmaceutical Technology

The collaboration, under a sponsored research agreement, will focus on mRNA vaccines that can help in modulating the normal immune response of the body for the treatment of certain autoimmune diseases as well as allergic conditions. Cell & Gene Therapy coverage on Pharmaceutical Technology is supported by Cytiva.

article thumbnail

Market Your Pharmacy with a 2023 Health Awareness Calendar

Digital Pharmacist

World Immunization Week: April 24-30. National Immunization Awareness Month. Cervical Health Awareness Month | S hare downloadable content from the NCCC and advocate for HPV vaccinations. World Immunization Week | Post a flyer and share a list on social media of your vaccination offerings. . National Kidney Month.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Kite and Daiichi Sankyo update cell therapy licensing agreement

Pharmaceutical Technology

Directed against a cell membrane protein called CD19, Yescarta uses the immune system of the patient to destroy cancer. By clicking the Download Free Whitepaper button, you accept the terms and conditions and acknowledge that your data will be used as described in the Cytiva Thematic privacy policy. By Cytiva Thematic.

article thumbnail

Hospital Universitario and Josep Carreras develop cell therapy for leukaemia

Pharmaceutical Technology

CAR-T therapies are based on the patient’s immune cell modification and can express artificial chimeric receptors that can identify and remove tumour cells. By clicking the Download Free Whitepaper button, you accept the terms and conditions and acknowledge that your data will be used as described in the Cytiva Thematic privacy policy.

Hospitals 110
article thumbnail

Sanofi and Queensland collaborate to build $190m research facility

Pharmaceutical Technology

mRNA technology is projected to offer a new generation of vaccines that direct specific cells to generate proteins that are detected by the immune system to develop a defence. Additionally, the hub could bring more capabilities, supply-chain expertise and clinical assessments to the region. By Cytiva Thematic.

article thumbnail

Liminatus Pharma enters SPAC merger deal with Iris Acquisition

Pharmaceutical Technology

A clinical-stage biopharmaceutical firm, Liminatus focuses on the development of new therapies for cancer that utilises the immune system of the body to detect and fight cancer cells. It can induce immune responses against Guanylyl Cyclase C (GCC) expressing colorectal, pancreatic, gastric and oesophageal cancers. By Cytiva Thematic.

article thumbnail

Boehringer Ingelheim partners with 3T Biosciences for cancer therapies

Pharmaceutical Technology

The collaboration will combine 3T Biosciences’ 3T- T-Cell Receptor Antigen and Cross-Reactivity Engine (TRACE) discovery platform with Boehringer Ingelheim’s two-pronged research strategy combining compounds that are directed towards cancer cells and target immune cells. By Cytiva Thematic.